Clinical trial
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201
Study timeline
Study start (actual)2020-11-30Date precision: day
Registry last updated2025-02-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
Sponsors & collaborators
China Medical University Hospitallead sponsor
Ministry of Science and Technology, Taiwancollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04959201 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.